RUSSO, PIERLUIGI
 Distribuzione geografica
Continente #
AS - Asia 86
NA - Nord America 77
EU - Europa 31
SA - Sud America 8
AF - Africa 4
Totale 206
Nazione #
US - Stati Uniti d'America 74
CN - Cina 38
SG - Singapore 28
RU - Federazione Russa 15
KR - Corea 11
BR - Brasile 8
IE - Irlanda 8
VN - Vietnam 4
FR - Francia 3
BJ - Benin 2
MX - Messico 2
PL - Polonia 2
CA - Canada 1
CZ - Repubblica Ceca 1
EG - Egitto 1
ES - Italia 1
FI - Finlandia 1
IN - India 1
IQ - Iraq 1
JP - Giappone 1
LB - Libano 1
NG - Nigeria 1
PK - Pakistan 1
Totale 206
Città #
Hefei 22
Santa Clara 15
Singapore 13
San Jose 11
Seoul 11
Moscow 9
Dallas 8
Dublin 8
Ashburn 7
Beijing 4
Boardman 3
Chandler 3
Ho Chi Minh City 3
Lauterbourg 3
Buffalo 2
Chicago 2
Cotonou 2
Council Bluffs 2
New York 2
Warsaw 2
Abuja 1
Alexandria 1
Brooklyn 1
Caxias do Sul 1
Cheb 1
Durango 1
Garanhuns 1
Hangzhou 1
Hillah 1
Islamabad 1
La Cañada 1
Lappeenranta 1
Macapá 1
Novo Hamburgo 1
Pinhais 1
Pune 1
Rio de Janeiro 1
San Antonio 1
Santa Maria da Vitória 1
Seattle 1
São Francisco do Sul 1
Tianjin 1
Tokyo 1
Washington 1
Totale 156
Nome #
How many chronic myeloid leukemia patients who started a frontline second-generation tyrosine kinase inhibitor have to switch to a second-line treatment? A retrospective analysis from the monitoring registries of the italian medicines agency (AIFA) 88
Mortality rate in patients with chronic myeloid leukemia in chronic phase treated with frontline second generation tyrosine kinase inhibitors: a retrospective analysis by the monitoring registries of the Italian Medicines Agency (AIFA) 76
The impact of starting dose on overall survival in myelofibrosis patients treated with ruxolitinib: A prospective real‐world study on AIFA monitoring registries 48
Totale 212
Categoria #
all - tutte 737
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 737


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202323 0 0 0 0 6 4 0 4 8 0 0 1
2023/202414 1 0 2 1 0 6 0 1 0 0 1 2
2024/202549 0 4 3 0 13 7 3 0 3 5 5 6
2025/2026126 12 27 15 2 24 18 20 3 1 4 0 0
Totale 212